The Duke/UNC ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from UNC Pembroke, North Carolina Central University, and East Carolina University.
Areas of focus will include identifying age-related changes that impact the development, progression and experience of Alzheimer’s and related dementias, and how factors that arise in early- and mid-life contribute to racial, ethnic and geographic disparities in dementia.
The Division of Neuromuscular Disorders has been designated as a GBS|CIDP Foundation International Center of Excellence for the diagnosis and treatment of Guillain-Barre Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and other inflammatory peripheral neuropathies.
Second-year Adult Neurology resident Dr. Laura de Lima Xavier received the award during the 2021 UNC School of Medicine’s Whitehead Lecture and Awards ceremony on August 4.
Learn about aducanumab and UNC Neurology’s position on the new drug approved by the FDA for Alzheimer’s disease.
Jorge L. Almodóvar-Suárez, MD, associate professor of general neurology and neuromuscular disorders, is the new director of the UNC Department of Neurology’s Amyotrophic Lateral Sclerosis (ALS) Clinic. Born and raised in Puerto Rico, Dr. Almodóvar-Suárez is graduate of the state-funded University of Puerto Rico System, and a faithful believer of education and health care for … Read more
The UNC Department of Neurology is proud to announce that UNC neurologists Clio Rubinos, MD, MS, and Miriam Sklerov, MD, MS, have both received UNC School of Medicine Physician Scientist Training Program Faculty Awards.
